Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636049012 | Teneligliptin hydrobromide (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4636050012 | Teneligliptin hydrobromide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Teneligliptin hydrobromide (substance) | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Teneligliptin hydrobromide (substance) | Is a | Dipeptidyl peptidase IV inhibitor | true | Inferred relationship | Some | ||
| Teneligliptin hydrobromide (substance) | Is a | Carboxylic acid and/or carboxylic acid derivative (substance) | true | Inferred relationship | Some | ||
| Teneligliptin hydrobromide (substance) | Has disposition (attribute) | Dipeptidyl peptidase IV inhibitor (disposition) | true | Inferred relationship | Some | ||
| Teneligliptin hydrobromide (substance) | Is modification of (attribute) | Teneligliptin (substance) | true | Inferred relationship | Some | ||
| Teneligliptin hydrobromide (substance) | Is a | Drug or medicament (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely teneligliptin (as teneligliptin hydrobromide) 20 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Teneligliptin hydrobromide (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR